Participate

Press Releases

Cyveillance Helps U.S. Food and Drug Administration...

Over 60 Million Domains Analyzed to Study Depth and Breadth of Problem

ARLINGTON, Va.--June 13, 2005--Cyveillance, ...

on 2005-06-13 06:21:35

...Identify Online Pharmacy Misrepresentation

Over 60 Million Domains Analyzed to Study Depth and Breadth of Problem

ARLINGTON, Va.--June 13, 2005--Cyveillance, the leading provider of online risk monitoring and management solutions, today announced the findings of research done at the request of the U.S. Food and Drug Administration (FDA). The FDA needed to accurately assess the proliferation of online sites that appeared to be Canadian pharmacies offering prescription drugs at a discount. The FDA chose Cyveillance and its industry leading Internet monitoring technology to help locate and quantify online Canadian pharmacy sales and to identify how many of the thousands of sites were potentially fraudulent.

"The FDA partnership is a good example of the kind of proactive, preventative measures that can be taken against fraudulent activity online with relevant analytical intelligence," said Todd Bransford, vice president of marketing for Cyveillance. "While our customers are usually large organizations with prominent online operations, increasingly it is the end user who benefits since all online consumers want a safe and secure online environment. We're pleased that we helped the FDA identify large-scale misrepresentation online in the case of online pharmacy sales."

Starting from the entire Internet universe encompassing millions of web sites, Cyveillance analysis discovered approximately 11,000 sites that were designed to appear as Canadian pharmacy sites. Of these sites, only 1,009 sites actually sold prescription products. After further detailed analysis, only 214 of those 1,009 had any registration data indicating a registrant or owner address located in Canada, or exhibited any data suggesting they were hosted by a Canadian Internet Service Provider (ISP). Certain patterns emerged as well from analysis of the fraudulent sites, for example the fact that over half of the sites registered in the United States and dispensing drugs were registered to a single firm. These facts and other actionable data were forwarded to the FDA to support congressional testimony on this controversial issue.

Cyveillance focuses on helping organizations monitor the Internet for issues such as identity theft, fraud, security risks, unauthorized product distribution and many forms of brand abuse. The company delivers actionable intelligence derived from comprehensive analysis, as opposed to projections based on limited online samples. Cyveillance customers use this intelligence to increase revenues, reduce costs, mitigate risk and in many cases to take steps that benefit the broader Internet user community.

About Cyveillance
Cyveillance provides online risk monitoring and management solutions to Global 2000 organizations. The company comprehensively monitors the Internet using patented technology to deliver early warning of threats to information, infrastructure and people. Armed with this actionable intelligence, Chief Security Officers can proactively protect their company's reputation, revenues and customer trust. Cyveillance counts over half of the Fortune 50 and three quarters of the top Fortune 500 companies in the financial services, pharmaceutical, energy, and technology industries as clients.

Use of this site is governed by our Terms of Use and Privacy Policy.
Copyright 1996- Ziff Davis, LLC. All Rights Reserved.
Reproduction in whole or in part in any form or medium without express written permission
of Ziff Davis, LLC. is prohibited.PCMag Digital GroupAdChoice